| dox-sl | <drug> A chemotherapy agent used for Kaposi's sarcoma consisting of a preparation of doxorubicin encapsulated in liposomes which deliver significantly greater quantities of doxorubicin to the KS lesions while reducing the drug's side effects. DOX-SL incorporates so-called stealth liposomes, whose polyethylene glycol (PEG) coating gives them still greater stability in the bloodstream. Side effects include nausea, vomiting, stomatitis, diarrhoea and hair loss. DOX-SL causes a significant amount of neutropenia, which can be managed with G-CSF. (10 Oct 1997) |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|